AARD

Healthcare Biotechnology

Aardvark Therapeutics, Inc.

$4.99

-0.28 -5.31% today

Price History

Not enough data

Key Stats

Market Cap

109.20M

Avg Volume

212,275

EPS

-$3.22

52W High

$17.94

52W Low

$3.35

Div. Yield

0.0%

Analyst Ratings

Hold

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-2.10

P/B Ratio

1.46

EV/EBITDA

-0.49

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(66.0%)

Return on Assets

(40.4%)

Liquidity & Leverage

Current Ratio

12.63

Quick Ratio

11.57

Debt / Equity

0.01

Total Cash

73.87M

Total Debt

677,000

About

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

aardvarktherapeutics.com